| WKY/NCrl |
systolic blood pressure |
controlled exposure to ambient light (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112.0 days
| 7 |
125.9 |
mmHg |
0.49 |
1.3 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
|
daytime (7 AM - 7 PM) |
70081 |
1281 |
| WKY/NCrl |
systolic blood pressure |
controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
112.0 days
| 7 |
130.0 |
mmHg |
0.57 |
1.5 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
|
nighttime (7 PM - 7 AM) |
70082 |
1281 |
| WKY/NCrl |
systolic blood pressure |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
115.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
103523 |
2827 |
| WKY/NCrl |
systolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 14 days) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126.0 days
| 7 |
126.4 |
mmHg |
1.06 |
2.8 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
|
daytime (7 AM - 7 PM) |
70085 |
1281 |
| WKY/NCrl |
systolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126.0 days
| 7 |
131.7 |
mmHg |
0.83 |
2.2 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
|
nighttime (7 PM - 7 AM) |
70086 |
1281 |
| WKY/NCrl |
systolic blood pressure |
vehicle control condition (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
168.0 days
| 6 |
126.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
|
|
measured 12 hr/night for 4 weeks |
nighttime measurement |
103534 |
2827 |
| WKY/NCrl |
systolic blood pressure |
vehicle control condition (for 28 days) and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
168.0 days
| 6 |
121.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
|
|
measured 12 hr/day for 4 weeks |
daytime measurement |
103526 |
2827 |
| WKY/NCrl |
systolic blood pressure |
salidroside (40 mg/kg) (for 28 days) and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
168.0 days
| 6 |
117.0 |
mmHg |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry |
|
|
|
measured 12 hr/day for 4 weeks |
daytime measurement |
103527 |
2827 |
| WKY/NCrl |
systolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
122.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
measured 12 hr/night for 1 week |
nighttime measurement |
103531 |
2827 |
| WKY/NCrl |
systolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
126.0 |
mmHg |
4.0 |
9.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
measured 12 hr/night for 1 week |
nighttime measurement |
103530 |
2827 |
| WKY/NCrl |
systolic blood pressure |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
121.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
103522 |
2827 |
| WKY/NCrl |
systolic blood pressure |
salidroside (40 mg/kg) (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
168.0 days
| 6 |
123.0 |
mmHg |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry |
|
|
|
measured 12 hr/night for 4 weeks |
nighttime measurement |
103535 |
2827 |
| WKY/NCrl |
systolic blood pressure |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
arterial blood pressure trait |
male |
84.0 days
| 10 |
139.0 |
mmHg |
5.0 |
15.81 |
tail cuff plethysmography |
|
0.0 |
|
|
|
109281 |
3141 |
| WKY/NCrl |
systolic blood pressure |
standard condition (for 126 days) |
Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4. |
arterial blood pressure trait |
male |
203.0 days-224.0 days |
10 |
179.0 |
mmHg |
3.0 |
9.49 |
tail cuff plethysmography |
tail |
0.0 |
|
|
standard rat chow |
107098 |
3075 |